Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Nature Communications|January 13, 2025
Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemiaFeng Wang, Luyao Zhao, Yun Tan, et al.
Leukemia & Lymphoma|March 26, 2015
Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapyYa-Zhen Qin, Lan-Ping Xu, Huan Chen, et al.
The Lancet. Oncology|June 10, 2018
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trialHong-Hu Zhu, De-Pei Wu, Xin Du, et al.
American Journal of Hematology|December 11, 2020
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemiaHuan-Ping Wang, Yi-Le Zhou, Xin Huang, et al.
Science Translational Medicine|November 27, 2024
A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal modelsSheng Zhao, Ziyi Lu, Ruisi Cai, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 18, 2022
A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemiaLi-Xia Zhu, Rong-Rong Chen, Lu-Lu Wang, et al.
The Lancet. Haematology|May 5, 2022
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trialHuafeng Wang, Liping Mao, Min Yang, et al.
Annals of Hematology|July 5, 2015
Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantationXiao-Hui Zhang, Guo-Xiang Wang, Hong-Hu Zhu, et al.
Ebiomedicine|August 20, 2015
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic TrioxideYang Shen, Ya-Kai Fu, Yong-Mei Zhu, et al.
Cancer Letters|November 16, 2018
ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferationJia-Min Zhang, Chen-Cong Wang, Gao-Chao Zhang, et al.
Pageof 13